Found: 59
Select item for more details and to access through your institution.
Antifungal mechanism of action of Schinus lentiscifolius Marchand essential oil and its synergistic effect in vitro with terbinafine and ciclopirox against dermatophytes.
- Published in:
- Journal of Pharmacy & Pharmacology, 2018, v. 70, n. 9, p. 1216, doi. 10.1111/jphp.12949
- By:
- Publication type:
- Article
Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 5, p. 655, doi. 10.1093/jac/dki105
- By:
- Publication type:
- Article
Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 5, p. 663, doi. 10.1093/jac/dki089
- By:
- Publication type:
- Article
Contact dermatitis due to ciclopiroxolamine.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Dystrophic onychomycosis due to Microsporum gypseum.
- Published in:
- 2006
- By:
- Publication type:
- Letter
In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans.
- Published in:
- Mycoses, 2006, v. 49, n. 3, p. 159, doi. 10.1111/j.1439-0507.2006.01228.x
- By:
- Publication type:
- Article
Tinea capitis favosa in Poland.
- Published in:
- Mycoses, 2004, v. 47, n. 5/6, p. 257, doi. 10.1111/j.1439-0507.2004.00985.x
- By:
- Publication type:
- Article
Ciclopirox in the treatment of seborrhoeic dermatitis.
- Published in:
- Mycoses, 2002, v. 45, p. 238
- Publication type:
- Article
The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway.
- Published in:
- Oncogene, 2011, v. 30, n. 18, p. 2098, doi. 10.1038/onc.2010.590
- By:
- Publication type:
- Article
Ciclopirox: an overview.
- Published in:
- International Journal of Dermatology, 2001, v. 40, n. 5, p. 305, doi. 10.1046/j.1365-4362.2001.01156.x
- By:
- Publication type:
- Article
Transungual Delivery of Ciclopirox Is Increased 3–4-Fold by Mechanical Fenestration of Human Nail Plate in an In Vitro Model.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 1, p. 29, doi. 10.3390/pharmaceutics11010029
- By:
- Publication type:
- Article
Onychomycosis Due to Neoscytalidium Treated with Oral Terbinafine, Ciclopirox Nail Lacquer and Nail Abrasion: A Pilot Study of 25 Patients.
- Published in:
- Mycopathologia, 2013, v. 175, n. 1/2, p. 75, doi. 10.1007/s11046-012-9580-5
- By:
- Publication type:
- Article
Exploring the versatility of ciclopirox - from anti-fungal to anticancer agent and beyond.
- Published in:
- European Journal of Clinical & Experimental Medicine, 2023, v. 21, n. 4, p. 896, doi. 10.15584/ejcem.2023.4.26
- By:
- Publication type:
- Article
VIGNETTE IN CONTACT DERMATOLOGY Allergic contact dermatitis from ciclopirox olamine.
- Published in:
- Australasian Journal of Dermatology, 2001, v. 42, n. 2, p. 145, doi. 10.1046/j.1440-0960.2001.00501.x
- By:
- Publication type:
- Article
ルリコナゾール爪外用液のin vitro爪透過性試験およびスライス阻止円法による爪中薬物濃度分布および抗真菌活性評価
- Published in:
- Medical Mycology Journal, 2016, v. 57, n. 1, p. J19
- By:
- Publication type:
- Article
Nail dermoscopy (onychoscopy) is useful in diagnosis and treatment follow-up of the nail mixed infection caused by Pseudomonas aeruginosa and Candida albicans.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.
- Published in:
- Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii, 2015, v. 32, n. 1, p. 40, doi. 10.5114/pdia.2014.40968
- By:
- Publication type:
- Article
Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074414
- By:
- Publication type:
- Article
Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant <i>Acinetobacter baumannii</i>, <i>Escherichia coli</i>, and <i>Klebsiella pneumoniae</i>.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069646
- By:
- Publication type:
- Article
Antimycotic Ciclopirox Olamine in the Diabetic Environment Promotes Angiogenesis and Enhances Wound Healing.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027844
- By:
- Publication type:
- Article
Degradation and Impurity Profile Study of Ciclopirox Olamine after Pre-column Derivatization: A Risk Based Approach.
- Published in:
- Journal of Chromatographic Science, 2017, v. 55, n. 9, p. 899, doi. 10.1093/chromsci/bmx047
- By:
- Publication type:
- Article
Effects of VEGF on the Blood-Brain Barrier Disruption Caused by Hyperosmolarity.
- Published in:
- Pharmacology, 2008, v. 82, n. 3, p. 187, doi. 10.1159/000151433
- By:
- Publication type:
- Article
Ciclopirox olamine directly scavenges hydroxyl radical.
- Published in:
- International Journal of Dermatology, 2008, v. 47, n. 1, p. 15, doi. 10.1111/j.1365-4632.2007.03359.x
- By:
- Publication type:
- Article
Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis.
- Published in:
- International Journal of Dermatology, 2006, v. 45, n. 1, p. 66, doi. 10.1111/j.1365-4632.2004.02331.x
- By:
- Publication type:
- Article
Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
- Published in:
- International Journal of Dermatology, 2005, v. 44, n. 7, p. 590, doi. 10.1111/j.1365-4632.2004.02559.x
- By:
- Publication type:
- Article
Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties.
- Published in:
- International Journal of Dermatology, 2004, v. 43, p. 3, doi. 10.1111/j.1461-1244.2004.02380.x
- By:
- Publication type:
- Article
Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: Results of a randomized, double-blind, vehicle-controlled trial.
- Published in:
- International Journal of Dermatology, 2004, v. 43, p. 9, doi. 10.1111/j.1461-1244.2004.02381.x
- By:
- Publication type:
- Article
Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: Results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.
- Published in:
- International Journal of Dermatology, 2004, v. 43, p. 13, doi. 10.1111/j.1461-1244.2004.02382.x
- By:
- Publication type:
- Article
Ciclopirox 1% shampoo is a safe and effective treatment for seborrheic dermatitis.
- Published in:
- International Journal of Dermatology, 2004, v. 43, p. 1, doi. 10.1111/j.1461-1244.2004.02383.x
- By:
- Publication type:
- Article
Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: Results of a double-blind, vehicle-controlled trial.
- Published in:
- International Journal of Dermatology, 2004, v. 43, p. 17, doi. 10.1111/j.1461-1244.2004.02409.x
- By:
- Publication type:
- Article
Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel.
- Published in:
- International Journal of Dermatology, 2003, p. 23, doi. 10.1046/j.1365-4362.42.s1.1.x
- By:
- Publication type:
- Article
Ciclopirox for the treatment of superficial fungal infections: a review.
- Published in:
- International Journal of Dermatology, 2003, p. 3, doi. 10.1046/j.1365-4362.42.s1.2.x
- By:
- Publication type:
- Article
Ciclopirox gel: an update.
- Published in:
- International Journal of Dermatology, 2003, p. 1, doi. 10.1046/j.1365-4362.42.s1.3.x
- By:
- Publication type:
- Article
Ciclopirox gel for seborrheic dermatitis of the scalp.
- Published in:
- International Journal of Dermatology, 2003, p. 19, doi. 10.1046/j.1365-4362.42.s1.5.x
- By:
- Publication type:
- Article
Ciclopirox gel in the treatment of patients with interdigital tinea pedis.
- Published in:
- International Journal of Dermatology, 2003, p. 29, doi. 10.1046/j.1365-4362.42.s1.6.x
- By:
- Publication type:
- Article
Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.
- Published in:
- International Journal of Dermatology, 2003, p. 11, doi. 10.1046/j.1365-4362.42.s1.4.x
- By:
- Publication type:
- Article
Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2013, v. 27, n. 2, p. e153, doi. 10.1111/j.1468-3083.2012.04529.x
- By:
- Publication type:
- Article
An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2009, v. 23, n. 7, p. 773, doi. 10.1111/j.1468-3083.2009.03164.x
- By:
- Publication type:
- Article
Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2005, v. 19, n. 1, p. 21, doi. 10.1111/j.1468-3083.2004.00988.x
- By:
- Publication type:
- Article
Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2016, v. 468, n. 11/12, p. 1957, doi. 10.1007/s00424-016-1887-5
- By:
- Publication type:
- Article
Ciclopirox: Recent Nonclinical and Clinical Data Relevant to its Use as a Topical Antimycotic Agent.
- Published in:
- Drugs, 2010, v. 70, n. 16, p. 2133, doi. 10.2165/11538110-000000000-00000
- Publication type:
- Article
Onychomycosis Does Not Always Require Systemic Treatment for Cure: A Trial Using Topical Therapy.
- Published in:
- Pediatric Dermatology, 2013, v. 30, n. 3, p. 316, doi. 10.1111/pde.12064
- By:
- Publication type:
- Article
A Randomized, Double-Blind Study Comparing the Efficacy of Selenium Sulfide Shampoo 1% and Ciclopirox Shampoo 1% as Adjunctive Treatments for Tinea Capitis in Children.
- Published in:
- Pediatric Dermatology, 2010, v. 27, n. 5, p. 459, doi. 10.1111/j.1525-1470.2010.01093.x
- By:
- Publication type:
- Article
Ciclopiroxolamine Cream 1% in the Treatment of Seborrhoeic Dermatitis: A Double-Blind, Parallel-Group Comparison with Ketoconazole and Vehicle in a Confirmatory Trial.
- Published in:
- Clinical Drug Investigation, 2002, v. 22, n. 3, p. 167, doi. 10.2165/00044011-200222030-00003
- By:
- Publication type:
- Article
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 459, p. 1, doi. 10.1126/scitranslmed.aat7467
- By:
- Publication type:
- Article
Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.
- Published in:
- Molecular Medicine Reports, 2018, v. 17, n. 3, p. 4291, doi. 10.3892/mmr.2018.8418
- By:
- Publication type:
- Article
Ciclopirox olamine: an antifungal alternative against cryptococcosis.
- Published in:
- Letters in Applied Microbiology, 2010, v. 51, n. 5, p. 485, doi. 10.1111/j.1472-765X.2010.02914.x
- By:
- Publication type:
- Article
Oxidação do Ciclopirox em Eletrodo de Diamante: Estudo do Comportamento Voltamétrico e Determinação Eletroanalítica.
- Published in:
- Orbital: The Electronic Journal of Chemistry, 2014, v. 6, n. 3, p. 147
- By:
- Publication type:
- Article
Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161509
- By:
- Publication type:
- Article
Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0159661
- By:
- Publication type:
- Article